- · Covaxin awaits its final nod by the DCGI, after which it will become the second vaccine after ZyCoV-D, to be used for kids in India
- · On October 6, essential data regarding trials on children aged 2 to 18 years was submitted by Bharat Biotech to the DCGI
- · Novavax, by the Serum Institute of India (SII), has also received approval for the conduction of clinical trials among children aged 7-11 year, besides Covaxin and ZyCoV-D
On Tuesday, the subject expert committee (SEC) gave its nod for the usage of Bharat Biotech’s Covaxin in children aged 2 to 18 years. After the final approval by the Drug Controller General of India (DGCI), the vaccine will become the second one to be used for kids in India, following ZyCoV-D, which is a DNA-based vaccine prepared by Zydus Cadila.
On October 6, essential data regarding trials on children aged 2 to 18 years was submitted by Bharat Biotech to the DCGI. Earlier in May, the Hyderabad-based biotechnology company received approvals for conducting their Covid-19 vaccination trials on children.
According to Sanjay K Rai, who is a professor at the Centre for Community Medicine, All India Institute of Medical Sciences (AIIMS) and also the chief investigator of Covaxin trials on children, the trials aimed principally at three age groups, “Covaxin’s trial was done on three age groups. The first group examined was between 12-18 years, the second group was between 6-12 years and the third age group was between 2-6 years.”
Rai has further stated that the trials have discovered safety and immunity levels among children to be the same as that of adults. Novavax, which has been prepared by the Serum Institute of India (SII), has also received approval for the conduction of clinical trials among children aged 7-11 years, besides Covaxin and ZyCoV-D.
Experts believe that the third wave would be hazardous mostly to children, adding up to it, schools and educational institutions are on the brink of reopening across the country after a prolonged gap. Such circumstances have provoked the government of India to gear up the vaccination rates among children to the quickest.